• What is the best way to treat infected hip replacements? 5 April 2018 New research has found treating an infected hip replacement in a single stage procedure may be as effective or better than the widely used two-stage procedure. To date no well-designed study has compared these procedures head-to-head to decide if one is better or if they achieve the same results. Hip replacement is a very common operation that is effective at providing pain relief and improving mobility, however, infection can sometimes occur following joint replacement. The findings have wide implications for orthopaedic surgery, the NHS, and health systems worldwide.
  • Surgeries employing GPs with additional training in complementary medicine appear less likely to prescribe antibiotics 20 March 2018 Use of complementary/alternative medicine may help reduce over-prescribing of antibiotics
  • Forecast launched to help sheep farmers respond to annual spring threat to young lambs 7 March 2018 It may not feel like it in parts of the UK hit by 'The Beast from the East' and Storm Emma, but spring is just around the corner – and with it the annual deadly threat from the roundworm Nematodirus in lambs.
  • Watch fat cells help heal a wound in a fly 27 February 2018 Fat body cells in Drosophila play a surprising role in sealing wounds and preventing infection, researchers at the University of Bristol report in the journal Developmental Cell.
  • Tackling antimicrobial resistance worldwide 14 February 2018 Antimicrobial resistance (AMR) is a serious and growing global health challenge. It occurs when microorganisms (such as bacteria, fungi and viruses) emerge that cannot be killed by normal doses of an antimicrobial drug (such as antibiotics and antivirals), making them less susceptible or resistant to antimicrobial agents. AMR can jeopardise the success of surgery and chemotherapy, and could have grave implications for the future of modern medicine. As such, it is an urgent global threat which requires a coordinated cross-government, academic and industry response. A GW4 research community has brought together leading AMR expertise across four universities to help tackle this issue.
  • New targets revealed for the treatment of inflammatory conditions 14 February 2018 Research by the University of Bristol has shed light on the way our clotting cells and immune cells control their interactions with each other.
  • Lung cancer drug resistance explained by computer simulations 12 February 2018 Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer.
  • Antibiotic resistance in children’s E. coli is high when commonly prescribed antibiotics are used 2 February 2018 Antibiotic resistance in children’s E. coli, a bacteria that is the most common cause of urinary tract infection, is high against many antibiotics commonly prescribed in primary care and could make them ineffective as first-line treatments, warns a study led by researchers at the University of Bristol and Imperial College London.
  • Health Economics at Bristol updates 11 January 2018 The Health Economics at Bristol (HEB) team works closely with local and national policymakers and carries out methodological and applied research. Our three key research themes are the economics of health and care across the life course, efficiency and equity in decision-making, and methods for applied health economics.
  • Bristol appoints Professor Tavaré to lead new Faculty of Life Sciences 9 January 2018 Professor Jeremy Tavaré will take up the role of Dean when the University of Bristol’s new Faculty of Life Sciences is officially launched on 1 August this year.

Infection and immunity press releases

Press releases relating to infection and immunity on the University's central news pages.

Years iterator 2009201020112012201320142015201620172018
View all news
Edit this page